Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changepoint analysis of longitudinal OCT in optic neuritis: Structural stabilization dynamics and clinical correlates.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Feasibility of a narrative driven mobile video game cognitive training intervention to enhance executive function in post-stroke cognitive impairment.

Scientific reports·2026
Same author

Deep Learning-Based Automated Detection and Burden Assessment of Paramagnetic Rim Lesions on Quantitative Susceptibility Mapping in Patients With Multiple Sclerosis.

Korean journal of radiology·2026
Same author

Small vessel disease burden and response to induced hypertension therapy in small vessel occlusion stroke with early neurological deterioration.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Distinct remission immune architectures under rituximab and azathioprine in AQP4-IgG-positive neuromyelitis optica spectrum disorder.

Frontiers in immunology·2026
Same author

Assessment of Cortical Myelination in Patients with MS via T1-Weighted/FLAIR Ratio: A Longitudinal Follow-up Study.

AJNR. American journal of neuroradiology·2026

Related Experiment Video

Updated: Nov 25, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K

Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.

Hyunjin Kim1, Youngin Lee2,3, Yong-Hwan Kim2

  • 1Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Frontiers in Neurology
|December 17, 2020
PubMed
Summary

A new deep learning algorithm can distinguish neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS) using brain MRI scans. This AI tool offers comparable accuracy to neurologists, aiding in the differential diagnosis of these central nervous system inflammatory diseases.

Keywords:
brain magnetic resonance image (MRI)convolutional neural network (CNN)deep learningmultiple sclerosisneuromyelitis optica spectrum disorder

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K

Related Experiment Videos

Last Updated: Nov 25, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.1K

Area of Science:

  • Neuroimmunology
  • Medical Imaging
  • Artificial Intelligence in Medicine

Background:

  • Accurate differentiation between neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) is critical due to distinct treatment strategies and potential for MS therapies to exacerbate NMOSD.
  • Brain magnetic resonance imaging (MRI) is a key diagnostic tool, but clinical application of MRI-based research for distinguishing NMOSD from MS remains limited.
  • The study addresses the need for improved diagnostic tools to differentiate these similar yet distinct central nervous system inflammatory conditions.

Purpose of the Study:

  • To investigate the clinical applicability of a deep learning-based algorithm for the differential diagnosis of NMOSD and MS.
  • To evaluate the performance of a 3D convolutional neural network in distinguishing between NMOSD and MS patients.
  • To compare the diagnostic accuracy of the deep learning model against that of experienced neurologists.

Main Methods:

  • A cohort of 338 participants (213 MS patients, 125 NMOSD patients) was analyzed.
  • A 3D convolutional neural network was trained using fluid-attenuated inversion recovery (FLAIR) MRI images and clinical data.
  • The model's performance was assessed and compared to the diagnoses provided by two independent neurologists.

Main Results:

  • The deep learning model achieved an area under the receiver operating characteristic curve (AUC) of 0.82.
  • The model demonstrated a diagnostic accuracy of 71.1% (sensitivity 87.8%, specificity 61.6%) in differentiating NMOSD from MS.
  • The AI model's classification consistency surpassed the moderate intra-rater reliability observed in neurologists (κ = 0.47, 0.50).

Conclusions:

  • The developed deep learning model effectively differentiates NMOSD from MS with accuracy comparable to human experts.
  • The algorithm offers consistent classification, a significant advantage over subjective human interpretation in differential diagnosis.
  • This AI tool shows potential to assist clinicians in the accurate and efficient diagnosis of NMOSD and MS in clinical practice.